Claro Scientific LLC is the developer of an instrument agnostic particle characterization technology called SpectraWave™. Using its unique SpectraWave technology, Claro provides consulting, particle characterization services, and custom instrumentation to a variety of clients worldwide.
Claro’s SpectraWave’s technology has been used to quantitatively characterize a variety of complex biological systems and fluids such as whole blood, blood components, urine analytes, and complicated multiple component systems such as pathogens in blood. In areas such as the biopharma and pharma space, Claro has used its technology to help clients solve problems with formulations, high concentration protein environments, protein aggregation, and vaccine development.
Located in St. Petersburg Florida, Claro began operations in 2006.